News By Tag
News By Place
Cures Within Reach Launches 100 Projects in 100 Days Initative
Researchers and clinicians join together to drive more treatments to more patients more quickly
Repurposing uses existing drugs, devices and nutriceuticals to create treatments for unsolved diseases. “We are rallying researchers, clinicians and their peers to post their repurposing proposals and ideas to CureAccelerator (https://app.cureaccelerator.org/
The process is easy. Individuals simply create a profile on CureAccelerator (https://app.cureaccelerator.org/
“By posting repurposing projects, researchers and clinicians can show funders what’s possible, highlight their institutions expertise, and be the first to know about repurposing funding announcements released in 2016,” said Dr. Bloom.
During the 100 Projects in 100 Days campaign, many new funding opportunities will be released on CureAccelerator, including a partnership program between the Canadian Institutes of Health Research and Cures Within Reach, with additional support from the Mindset Foundation and Mitacs. This partnership seeks research repurposing drugs for rare diseases, and incentivizes cross-border collaboration. Additional repurposing research funding opportunities will be released in specific geographic areas including the Mid-Atlantic and Midwest regions, and with disease-specific interests including Idiopathic Pulmonary Fibrosis, Alzheimer’s and Glaucoma.
ABOUT CURES WITHIN REACH
Cures Within Reach (http://www.cureswithinreach.org) works to catalyze repurposing research to quickly and affordably improve patient lives. We accomplish this through collaborations that connect researchers and funding, by facilitating crowd sourcing and community, and by identifying alternative financing models and incentives.
Cures Within Reach’s medical research projects have generated 12 repurposing treatments making an impact in the following diseases through off-label use in clinical practice or through a commercialization track: autoimmune lymphoproliferative syndrome, familial dysautonomia, Types 1 and 2 diabetes, lung cancer, multiple sclerosis, prostate cancer, myelodysplastic syndrome and 4 additional pediatric auto-immune diseases.
The organization uses CureAccelerator™
Visit us at www.cureswithinreach.org or follow us via Twitter.com/